Literature DB >> 7840108

Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan.

K Nakashima1, S Kashiwagi, W Kajiyama, M Hirata, J Hayashi, A Noguchi, K Urabe, K Minami, Y Maeda.   

Abstract

The authors investigated the prevalence of antibody to human T-lymphotropic virus type I (anti-HTLV-I) in 409 female prostitutes, 446 patients with an episode of sexually transmitted diseases, and 17,345 control blood donors. All subjects were Japanese and all studies were done in Fukuoka, Kyushu, Japan, in 1989. The prevalence of anti-HTLV-I was significantly higher in the prostitutes (5.1%, p < 0.001), in the male patients (2.8%, p < 0.05), and in the female patients (5.7%, p < 0.05) than in the controls (males 1.4%, females 2.2%). Prevalence of anti-HTLV-I in the prostitutes increased with the number of years spent in prostitution, but the increase was not statistically significant. Among the subjects with sexually transmitted diseases, female prostitutes with syphilis, male patients with non-gonococcal urethritis, female patients with syphilis, and female patients with gonorrhea had a significantly higher prevalence of anti-HTLV-I than did the controls. A longitudinal study was done on the 168 prostitutes. Two (1.3%) of the 158 initially seronegative subjects seroconverted over the period of 2 years. These data suggest that the risk of male-to-female transmission of HTLV-I through sexual contact is high among high risk groups in Japan, and they support the possibility of female-to-male transmission of HTLV-I.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7840108     DOI: 10.1093/aje/141.4.305

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Prevalence of hepatitis C virus infection among female prostitutes in Fukuoka, Japan.

Authors:  K Nakashima; S Kashiwagi; J Hayashi; K Urabe; K Minami; Y Maeda
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

2.  Quantitative assessment of subclinical spasticity in human T-cell lymphotropic virus type I infection.

Authors:  J R Zunt; J O Alarcón; S Montano; W T Longstreth; R Price; K K Holmes
Journal:  Neurology       Date:  1999-07-22       Impact factor: 9.910

Review 3.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

4.  Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.

Authors:  Daniela Romer; David W Brighty; Cynthia L Robson; Quentin J Sattentau
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

5.  Cervical shedding of human T cell lymphotropic virus type I is associated with cervicitis.

Authors:  Joseph R Zunt; Charlene S Dezzutti; Silvia M Montano; Katherine K Thomas; Jorge O V Alarcón; Eberth Quijano; Barry N Courtois; Jorge L Sánchez; Pablo Campos; Eduardo Gotuzzo; Patricia C Guenthner; Renu B Lal; King K Holmes
Journal:  J Infect Dis       Date:  2002-11-06       Impact factor: 5.226

6.  Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.

Authors:  Lloyd Einsiedel; Richard J Woodman; Maria Flynn; Kim Wilson; Olivier Cassar; Antoine Gessain
Journal:  BMC Public Health       Date:  2016-08-15       Impact factor: 3.295

7.  Very high prevalence of infection with the human T cell leukaemia virus type 1c in remote Australian Aboriginal communities: Results of a large cross-sectional community survey.

Authors:  Lloyd Einsiedel; Hai Pham; Mohammad Radwanur Talukder; Kerry Taylor; Kim Wilson; John Kaldor; Antoine Gessain; Richard Woodman
Journal:  PLoS Negl Trop Dis       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.